Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis

Abstract

Our results show that CSF fetuin-A is a biomarker of disease activity and natalizumab response in MS. Neuronal expression of fetuin-A suggests that fetuin-A may play a pathological role in the disease process.